Modulatory Effect of Human Plasma on the Internal Nanostructure and Size Characteristics of Liquid-Crystalline Nanocarriers

被引:59
作者
Azmi, Intan Diana Mat [1 ]
Wu, Linping [2 ]
Wibroe, Peter Popp [2 ]
Nilsson, Christa [1 ]
Ostergaard, Jesper [1 ]
Sturup, Stefan [1 ]
Gammelgaard, Bente [1 ]
Urtti, Arto [3 ,4 ]
Moghimi, Seyed Moein [2 ]
Yaghmur, Anan [1 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Nanomed Lab, Ctr Pharmaceut Nanotechnol & Nanotoxicol, DK-2100 Copenhagen, Denmark
[3] Univ Helsinki, Ctr Drug Res, FIN-00014 Helsinki, Finland
[4] Univ Eastern Finland, Sch Pharm, FIN-70211 Kuopio, Finland
关键词
PARTICLES; PHASE; DRUG; NANOPARTICLES; CUBOSOMES; DISPERSIONS; GEL;
D O I
10.1021/acs.langmuir.5b00830
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The inverted-type liquid-crystalline dispersions comprising cubosomes and hexosomes hold much potential for drug solubilization and site-specific targeting on intravenous administration. Limited information, however, is available on the influence of plasma components on nanostructural and morphological features of cubosome and hexosome dispersions, which may modulate their stability in the blood and their overall biological performance. Through an integrated approach involving SAXS, cryo-TEM, and nanoparticle tracking analysis (NTA) we have studied the time-dependent effect of human plasma (and the plasma complement system) on the integrity of the internal nanostructure, morphology, and fluctuation in size distribution of phytantriol (PHYT)-based nonlamellar crystalline dispersions. The results indicate that in the presence of plasma the internal nanostructure undergoes a transition from the biphasic phase (a bicontinuous cubic phase with symmetry Pn3m coexisting with an inverted-type hexagonal (H-2) phase) to a neat hexagonal (H-2) phase, which decreases the median particle size. These observations were independent of a direct effect by serum albumin and dispersion-mediated complement activation. The implication of these observations in relation to soft nanocarrier design for intravenous drug delivery is discussed.
引用
收藏
页码:5042 / 5049
页数:8
相关论文
共 44 条
  • [21] CUBIC LIPID-WATER PHASES - STRUCTURES AND BIOMEMBRANE ASPECTS
    LARSSON, K
    [J]. JOURNAL OF PHYSICAL CHEMISTRY, 1989, 93 (21) : 7304 - 7314
  • [22] Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma
    Leesajakul, W
    Nakano, M
    Taniguchi, A
    Handa, T
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2004, 34 (04) : 253 - 258
  • [23] LjusbergWahern H, 1996, CHIM OGGI, V14, P40
  • [24] Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants II: Role of Plasma Esterases in Drug Release
    Lu, Xiuling
    Howard, Melissa D.
    Talbert, Dominique R.
    Rinehart, John J.
    Potter, Philip M.
    Jay, Michael
    Leggas, Markos
    [J]. AAPS JOURNAL, 2009, 11 (01): : 120 - 122
  • [25] Phase transformations in self-assembly systems for drug delivery applications
    Malmsten, Martin
    [J]. JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2007, 28 (01) : 63 - 72
  • [26] Soft drug delivery systems
    Malmsten, Martin
    [J]. SOFT MATTER, 2006, 2 (09) : 760 - 769
  • [27] Cubosomes for ruthenium complex delivery: formulation and characterization
    Mangiapia, Gaetano
    Vaccaro, Mauro
    D'Errico, Gerardino
    Frielinghaus, Henrich
    Radulescu, Aurel
    Pipich, Vitaliy
    Carnerup, Anna M.
    Paduano, Luigi
    [J]. SOFT MATTER, 2011, 7 (22) : 10577 - 10580
  • [28] Chelating oleyl-EDTA amphiphiles: self-assembly, colloidal particles, complexation with paramagnetic metal ions and promise as magnetic resonance imaging contrast agents
    Moghaddam, Minoo J.
    de Campo, Liliana
    Waddington, Lynne J.
    Weerawardena, Asoka
    Kirby, Nigel
    Drummond, Calum J.
    [J]. SOFT MATTER, 2011, 7 (22) : 10994 - 11005
  • [29] Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
    Moghimi, S. M.
    Hunter, A. C.
    Andresen, T. L.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52, 2012, 52 : 481 - 503
  • [30] Material properties in complement activation
    Moghimi, S. Moein
    Andersen, Alina J.
    Ahmadvand, Davoud
    Wibroe, Peter P.
    Andresen, Thomas L.
    Hunter, A. Christy
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (12) : 1000 - 1007